Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 21, 2025 08:00 ET | Source: AskBio Inc. (AskBio)

AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure

Research Triangle Park, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- First-in-human trial of investigational gene therapy AB-1002 designed to evaluate safety and preliminary efficacy in participants...
October 10, 2025 08:00 ET | Source: AskBio Inc. (AskBio)

AskBio Presents Interim Safety Results from Phase 1/Phase 2 LION-CS101 Clinical Trial of AB-1003 in Participants with Limb-Girdle Muscular Dystrophy 2I/R9

Research Triangle Park, N.C., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Data from first cohort of five participants suggest an acceptable safety profile for AB-1003 in participants with limb-girdle...
October 02, 2025 08:00 ET | Source: AskBio Inc. (AskBio)

AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meeting

Research Triangle Park, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) --One oral presentation and five poster presentations will highlight exciting progress in AskBio’s pipeline and advancements in the...
September 22, 2025 06:00 ET | Source: AskBio Inc. (AskBio)

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

Research Triangle Park, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- AB-1005, a glial cell line-derived neurotrophic factor (GDNF) investigational gene therapy, is being evaluated for the treatment...
September 17, 2025 08:00 ET | Source: AskBio Inc. (AskBio)

AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P)

Research Triangle Park, N.C., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Final participant randomized to complete enrollment in Phase 1 clinical trial assessing safety of investigational gene therapy...
September 16, 2025 17:17 ET | Source: D S Simon

Expert with Bayer Discusses the U.S. Launch of Aspirina Families with YourUpdateTV

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bayer’s Aspirina, the #1 pain relief option in Mexico* and a leading brand across Latin America, is now available in the United States. Recently, Dr....
August 21, 2025 08:02 ET | Source: AgTech Breakthrough

Bayer's E.L.Y. Wins “AI-based AgTech Solution of the Year” In 2025 AgTech Breakthrough Awards Program

LOS ANGELES, Aug. 21, 2025 (GLOBE NEWSWIRE) -- AgTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global agricultural...
June 27, 2025 15:51 ET | Source: Cohen Milstein Sellers & Toll PLLC

Court Approves $38M Cash Settlement Against Bayer AG in Hard-Fought Securities Class Action

Following the Bayer-Monsanto merger, litigation has resulted in a valuable settlement that, pending final approval, affirms the rights of ADR investors to
May 27, 2025 08:51 ET | Source: AskBio Inc. (AskBio)

AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders

Research Triangle Park, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- AB-1005 was well tolerated with no attributed serious adverse events in participants with mild or moderate Parkinson’s disease (PD)...
May 19, 2025 08:07 ET | Source: AskBio Inc. (AskBio)

AskBio Presents Complete Results of Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure at European Society of Cardiology Heart Failure Meeting

Research Triangle Park, N.C., May 19, 2025 (GLOBE NEWSWIRE) --First-in-human trial of AB-1002 designed to evaluate safety and preliminary efficacy in participants with New York Heart Association...